Table 3.
Risk of bias and study quality assessment
| Study | Non-burn comparison group? | Validated measure or confirmed diagnosis | Power analysis | Appropriate analysis | Prospective or longitudinal design (> 18mo) | Total |
|---|---|---|---|---|---|---|
| Boles, 2018 | 0 | 1 | 0 | 1 | 1 | 3 |
| Brown, 2014 | 0 | 1 | 1 | 1 | 0 | 3 |
| Brown, 2014 | 0 | 1 | 1 | 1 | 0 | 3 |
| Bushroe, 2018 | 1 | 1 | 0 | 1 | 0 | 4 |
| Chester, 2018 | 0 | 1 | 1 | 1 | 0 | 3 |
| Chrapusta, 2014 | 0 | 1 | 0 | 1 | 0 | 2 |
| Conn, 2017 | 0 | 0 | 1 | 1 | 0 | 2 |
| DeYoung, 2012 | 0 | 1 | 0 | 1 | 0 | 2 |
| DeYoung, 2014 | 0 | 1 | 0 | 1 | 0 | 2 |
| Duke, 2018 | 1 | 1 | 0 | 1 | 1 | 4 |
| Enlow, 2019 | 0 | 1 | 1 | 1 | 0 | 3 |
| Goodhew, 2014 | 0 | 1 | 0 | 1 | 1 | 3 |
| Graf, 2011 | 0 | 1 | 0 | 1 | 0 | 2 |
| Haag, 2017 | 0 | 1 | 0 | 1 | 0 | 3 |
| Hyland, 2015 | 0 | 1 | 1 | 1 | 0 | 3 |
| Jeffs, 2014 | 0 | 1 | 1 | 1 | 0 | 3 |
| Khadra, 2018 | 0 | 1 | 1 | 1 | 0 | 3 |
| Laitakari, 2015 | 1 | 1 | 0 | 1 | 1 | 4 |
| Maskell, 2013, 2014 | 1 | 1 | 1 | 1 | 0 | 4 |
| Murphy, 2015 | 1 | 1 | 0 | 1 | 1 | 4 |
| Nelson, 2020 | 0 | 1 | 0 | 1 | 0 | 2 |
| Nicolosi, 2013 | 0 | 1 | 0 | 1 | 1 | 3 |
| Nodoushani, 2018 | 0 | 0 | 0 | 0 | 1 | 1 |
| Pardo, 2010 | 0 | 1 | 0 | 1 | 0 | 2 |
| Parlak Gurol, 2010 | 0 | 1 | 0 | 1 | 0 | 2 |
| Quezada, 2016 | 0 | 1 | 0 | 1 | 1 | 3 |
| Rezazadeh, 2020 | 0 | 1 | 1 | 1 | 0 | 3 |
| Rimmer, 2014a/b | 0 | 1 | 0 | 1 | 0 | 2 |
| Riobueno-Naylor, 2020 | 0 | 1 | 0 | 1 | 1 | 3 |
| Rosenberg, 2015 | 0 | 1 | 0 | 1 | 1 | 3 |
| Russell, 2013 | 0 | 1 | 0 | 1 | 1 | 3 |
| Sharp, 2010 | 0 | 1 | 1 | 1 | 0 | 3 |
| Stoddard, 2011 | 0 | 1 | 0 | 1 | 0 | 2 |
| Sveen, 2012 | 0 | 1 | 0 | 1 | 1 | 3 |
| Thomas, 2012 | 0 | 1 | 0 | 1 | 0 | 2 |
| Tropez-Arceneaux, 2017 | 0 | 1 | 0 | 0 | 1 | 2 |
| Warner, 2012 | 0 | 1 | 0 | 1 | 1 | 3 |
| Weedon, 2011 | 0 | 1 | 0 | 1 | 0 | 3 |
| Willebrand, 2011 | 0 | 1 | 0 | 1 | 0 | 2 |
Note: 1 = present, 0 = not present